Nature Medicine: doi: /nm.4411

Similar documents
Viral Reservoirs and anti-latency interventions in nonhuman primate models of SIV/SHIV infection

a r t i c l e s Defining total-body AIDS-virus burden with implications for curative strategies

IMPC phenotyping SOPs in JMC

Drug Penetration to Sanctuary Sites Oral vs. IV Administration

USING MASS SPECTROMETRY IMAGING TO VISUALIZE DRUG DISTRIBUTION IN PUTATIVE VIRAL RESERVOIRS

Pharmacology Considerations for HIV Prevention

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys

HIV Reservoirs in Developing Countries: Implication for HIV CURE Strategies

Pharmacology Lessons from Chemoprophylaxis Studies. Marta Boffito, MD, PhD St Stephen s AIDS Trust Chelsea and Westminister Hospital London, UK

Novel Approaches for the Assessment of the In Vivo Residual Virus Pool and Viral Eradication Strategies in SIV-infected Rhesus Macaques

Received 4 December 2001/Accepted 29 April 2002

Early treatment of SIV plus macaques with an alpha(4)beta(7) mab alters virus distribution and preserves CD4(+) T cells in later stages of infection

CEA (CARCINOEMBRYONIC ANTIGEN)

SUPPLEMENTARY DATA: High immunoreactivity of the 99mTc-F(ab )2 fragments from in vitro binding studies: Biodistribution of 99mTc-F(ab )2 anti-cd4.

Supporting Information

Van Rompay et al. Retrovirology 2012, 9:57

In vivo analysis of HIV replication and persistence in the myeloid compartment

Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog Mutation(s) and M184V

In Silico Pharmacokinetic/Pharmacodynamic Simulation Of Long Acting Tenofovir Injectable Formulation For Pre-exposure Prophylaxis Strategies

Supplementary Figures. Supplementary Figure 1. Treatment schematic of SIV infection and ARV and PP therapies.

Anatomy. Contents Brain (Questions)

DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED

Fetal Pig Visual Dissection Guide

Human Body Systems. The human body consists of 11 major systems.

SUPPLEMENTARY INFORMATION

Massive infection and loss of memory CD4 + T cells in multiple tissues during acute SIV infection

ARVs on an Empty Stomach: Food Interaction Studies in a resource Limited Setting

Innovative diagnostics for HIV, HBV and HCV

Anatomy of the Large Intestine

MT09 - Normal Human Tissue Microarray, FDA

HIV 101. Applications of Antiretroviral Therapy

Descriptive Histology

HIV 101: Fundamentals of HIV Infection

The Role of TAF in PrEP. Dr. Garrett has nothing to disclose

Supporting Information

The Impact of Immunoglobulin in Acute HIV Infection on the HIV Reservoir: A Pilot Randomized Controlled Trial

Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps

Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions

PART II! IMMUNE SENESCENCE!

Chapter 12: The Lymphatic System

Abstract HIV reservoirs are major barriers to the eradication of this infection despite the widespread use of combination antiretroviral therapy.

10/05/2016. PrEP : from proof of concept to real life. E. CUA Nice university hospital

CROI 2013: New Drugs for Treatment and PrEP

Pre-exposure Prophylaxis (PrEP)

Imaging B Cell Follicles to Investigate HIV/SIV Persistence. Elizabeth Connick, M.D. University of Arizona May 8, 2017

HIV cure: current status and implications for the future

Dr Anna Herasimtschuk

Supporting Information

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

HIV-1-infected Males and Females under Less-Drug Regimens Achieve Antiretroviral Levels above the Inhibitory Concentration in the Genital Tract.

Antiretroviral Pharmacology for PrEP: Enhancing RCT Understanding with Small Intensive Studies

Inves)gación básica y curación del VIH- 1

ID Week 2016: HIV Update

Anatomical Considerations for Lab Practical II

Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques

SUBJECTS 2nd year, 1st semester I. 1. Primitive gut - limits, derivatives 2. Foregut -limits, evolution, derivatives 3. Midgut -limits, evolution,

Replicating measles-shiv vaccine induces long term preservation of central memory CD4 cells in the gut of macaques challenged with SHIV89.

Since the introduction of the first vaccines by Edward Jenner

CROI 2016 Review: Immunology and Vaccines

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

LN04 - Lymphoma Tissue Microarray

Spleen. mlns. E Spleen 4.1. mlns. Spleen. mlns. Mock 17. Mock CD8 HIV-1 CD38 HLA-DR. Ki67. Spleen. Spleen. mlns. Cheng et al. Fig.

On Demand, Behaviorally-Congruent Rectal Microbicide Douche

What's new in the WHO ART guidelines How did markets react?

Efficient Liver Targeting and Uptake by Novel Tenofovir Prodrug, CMX157, For the Treatment of Hepatitis B

SYSTEMS BIOLOGY APPROACHES TO IDENTIFY MECHANISMS OF IMMUNE MEDIATED PROTECTION TRANSLATING RESEARCH INTO HEALTH

Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys

Next Generation PrEP? Injectable & Implantable ARVs

STRUCTURAL BASIS OF MEDICAL PRACTICE EXAMINATION 3. October 16, 2015

SHN-1 Human Digestive Panel Test results

Does Pharmacology Support Topical PrEP?

Professor Anna Maria Geretti

Distribution of Trichinella spiralis Larvae in Tissues of Swine

Hepatitis B Case Studies

Cell isolation. Spleen and lymph nodes (axillary, inguinal) were removed from mice

Detection of SIV in semen, urethra and male reproductive organs during efficient HAART

ART and Prevention: What do we know?

Criteria for Oral PrEP

The Human Body: An Overview of Anatomy. Anatomy. Physiology. Anatomy - Study of internal and external body structures

Body Regions Review. Anatomical Position. Anatomical Planes. Supine versus Prone 9/9/2009

Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques

Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update

Kerdiles et al - Figure S1

Clinical Case. Prof.ssa Cristina Mussini

Multi-normal human tissues, FDA, 96 samples, 35 organs/sites from three individuals (1.5mm)

HBA 531 THE BODY. Trunk Examination September 30, What is the effect of the parasympathetic nervous system on: (2.5)

BLT mice in HIV prophylaxis

Experimentally Infected Rhesus Monkeys

Darunavir STADA 400, 600 and 800 mg film-coated tablets , Version 1.1 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Professor Jonathan Weber

Supplementary Figure 1 IL-27 IL

Summary of treatment benefits

Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques

What do we measure when we measure cell associated HIV RNA

PK/PD: Gut vs Genital Tract

Lab Monitor Images Dissection of the Abdominal Vasculature + Lower Digestive System

The Struggle with Infectious Disease. Lecture 6

Important new concerns or changes to the current ones will be included in updates of Symtuza's RMP.

The Human Digestive System

Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013

Transcription:

Supplementary Figure 1. Plasma viral load decay characteristics in each of 4 monkey cohorts studied after prolonged ART. A. Decay in 5 SIV infected animals treated ART for 20-22 weeks. B, C. Decay in additional SIV infected animals treated with the ART drugs listed. D. Decay in 4 RT-SHIV+ animals treated with efavirenz (RFV), emtricitibine (FTC), and tenofovir (TFV).

Supplementary Figure 2. Comparison of qrt-pcr and RNAscope (A) and qpcr and DNAscope (B). Black symbols represent measures prior to ART and colored symbols represent measures during ART.

Supplementary Figure 3. Representative images from brain, kidney, liver, and lymph node using 35S SIV RNA ISH (red arrows) and SIV RNAscope (black arrows) to identify vrna+ cells. Supplementary Figure 4. Representative image of lymph node, DNA ISH using DNAscope. Red signal located over the nucleus of the cell identifies those cells that are vdna+ (black arrows).

Supplementary Figure 5. Change in peripheral blood CD4 T cells with ART in HIV-infected Ugandan patients. Supplementary Figure 6. Change in plasma Viral Load with ART in HIV-infected Ugandan patients.

Organ Average SIV RNA+ Cells/Gram Organ weight as a percentage of total weight (%) Total Cells/Organ Heart 7.54 x 10 3 0.44% 2.89 x 10 5 Brain 2.16 x 10 2 2.93% 5.58 x 10 4 Kidney (x2) 1.42 x 10 4 0.52% 1.29 x 10 6 Liver 1.88 x 10 3 3.17% 5.24 x 10 5 Gut 5.57 x 10 5 3.78% 1.86 x 10 8 Lungs (x2) 3.10 x 10 4 0.96% 5.26 x 10 6 LN 8.73 x 10 5 1.00% 7.68 x 10 7 Spleen 1.53 x 10 5 0.09% 1.19 x 10 6 Supplementary Table 1. Total estimated frequency of vrna+ cells in each organ system. Estimated vrna+ cells/gram of tissue from the animal sampled in acute infection were determined from a series of 5 sections from each organ and the average weight of each organ was estimated from the total weight of the animal using published necropsy literature to determine what average percent of the total body weight in a particular(1). Note the animal weight at necropsy was 8800 grams(1).

A. P568 (Peak Viremia) R096 (Early Chronic) P533 (Late Chronic) Brain 2.16 x 10 2 7.67 x 10 2 4.51 x 10 4 Heart ND ND 1.95 x 10 3 Lung 1.88 x 10 3 3.07 x 10 4 7.75 x 10 5 Liver 6.99 x 10 5 1.91 x 10 3 4.69 x 10 4 Kidney 3.10 x 10 4 2.83 x 10 4 8.14 x 10 2 Spleen 1.76 x 10 4 1.58 x 10 5 1.69 x 10 5 Axillary LN 1.53 x 10 5 2.51 x 10 6 1.80 x 10 6 Mesenteric LN 3.42 x 10 5 1.95 x 10 6 1.90 x 10 6 Inguinal LN 1.11 x 10 6 6.11 x 10 6 1.36 x 10 6 Colonic LN 5.10 x 10 5 3.59 x 10 6 3.88 x 10 6 Jejunum 5.82 x 10 5 7.87 x 10 5 3.31 x 10 6 Duodenum 2.05 x 10 5 5.27 x 10 5 3.92 x 10 4 Ileum 7.54 x 10 3 2.56 x 10 5 1.24 x 10 5 Ascending Colon 1.09 x 10 6 1.09 x 10 5 5.51 x 10 5 Transverse Colon 2.13 x 10 5 2.09 x 10 5 9.61 x 10 4 Rectum ND 9.17 x 10 5 7.59 x 10 6 Prostate 1.42 x 10 4 ND ND Seminal Vesicle 9.74 x 10 5 6.45 x 10 3 B. R365 R366 R367 R406 R410 Brain ND 1.80 x 10 3 ND 7.7 x 10 3 Heart ND ND ND 3.93 x 10 2 Lung 9.04 x 10 3 1.11 x 10 3 9.27 x 10 2 6.69 x 10 4 8.84 x 10 3 Liver ND 6.55 x 10 2 ND 1.67 x 10 3 1.86 x 10 2 Kidney ND 5.38 x 10 2 ND 5.48 x 10 2 8.77 x 10 2 Spleen ND 4.76 x 10 4 1.08 x 10 5 1.14 x 10 5 Axillary LN ND ND ND 6.69 x 10 4 1.18 x 10 3 Mesenteric LN 1.14 x 10 4 ND ND 7.64 x 10 4 1.87 x 10 4 Inguinal LN ND ND ND 1.10 x 10 4 1.71 x 10 4 Colonic LN 1.46 x 10 4 ND ND ND 1.05 x 10 5 Jejunum ND ND ND 2.93 x 10 6 1.76 x 10 5 Duodenum 2.98 x 10 3 2.52 x 10 5 4.78 x 10 4 1.11 x 10 6 4.05 x 10 4 Ileum 1.02 x 10 4 ND 1.11 x 10 6 4.87 x 10 6 2.92 x 10 4 Ascending Colon 2.47 x 10 4 6.54 x 10 4 1.01 x 10 6 1.09 x 10 5 7.16 x 10 5 Transverse Colon 2.11 x 10 4 2.15 x 10 5 4.08 x 10 5 3.01 x 10 6 5.45 x 10 5 Rectum 1.53 x 10 4 ND 3.42 x 10 5 Prostate * * * * * Seminal Vesicle * * * * * C. 35483 35609 36606 36650 Cerebrum ND 1.1 x 10 3 ND ND Cerebellum 3.7 x 10 2 ND ND ND Basal Ganglion ND ND Bone Marrow 2.5 x 10 4 3.7 x 10 5 ND 7.9 x 10 4 Lungs 2.3 x 10 4 6.2 x 10 4 1.6 x 10 3 1.2 x 10 5

Liver 4.8 x 10 3 6.2 x 10 4 ND 3.1 x 10 4 Thymus 9.1 x 10 3 1.1 x 10 5 ND 4.4 x 10 4 Spleen 2.5 x 10 5 3.6 x 10 6 1.4 x 10 5 2.8 x 10 6 Axillary LN 4.0 x 10 5 ND 7.0 x 10 3 2.4 x 10 6 Iliac LN 5.3 x 10 5 2.4 x 10 6 ND 4.4 x 10 6 Mesenteric LN 2.9 x 10 5 8.5 x 10 6 1.4 x 10 4 5.9 x 10 6 Inguinal LN 6.3 x 10 4 4.1 x 10 6 5.8 x 10 3 3.3 x 10 6 Jejunum 5.9 x 10 4 1.8 x 10 6 2.2 x 10 2 3.1 x 10 6 Ileum 1.5 x 10 3 3.9 x 10 6 1.4 x 10 4 3.9 x 10 5 Colon 6.7 x 10 4 2.4 x 10 5 1.1 x 10 3 5.8 x 10 5 D. 36348 35349 36166 35343 Cerebrum 1.1 x 10 2 2.4 x 10 2 1.2 x 10 2 1.1 x 10 2 Cerebellum ND Spinal Cord ND Bone Marrow ND ND ND ND Thymus ND ND ND ND Heart 1.8 x 10 2 Lungs 1.2 x 10 2 6.8 x 10 2 1.9 x 10 2 ND Liver 1.9 x 10 2 ND ND ND Kidney ND Spleen 3.3 x 10 2 2.8 x 10 2 6.0 x 10 2 ND Cervical LN ND Axillary LN 1.3 x 10 3 1.7 x 10 2 ND Iliac LN 3.5 x 10 3 1.4 x 10 3 7.8 x 10 2 ND Inguinal LN ND 3.2 x 10 2 1.1 x 10 3 ND Mesenteric LN 1.1 x 10 3 4.2 x 10 2 7.9 x 10 3 ND Jejunum ND ND 3.6 x 10 2 ND Duodenum ND Ileum 8.8 x 10 2 ND 2.8 x 10 2 7.6 x 10 2 Colon ND ND ND Supplementary Tables 2 A-D: Tables providing raw data on frequency of vrna+ cell/gram for each animal in each organ studied. Table 2A = 3 animals infected with SIV mac251 and sacrificed in acute, early and late chronic infection without ART, table 2B = macaques infected with SIV mac251 after 22 weeks of ART, Table 2C = 4 macaques infected with RT-SHIV and sacrificed after 26 weeks of infection without ART, and Table 1D = 5 macaques infected with RT-SHIV and sacrificed after 26 weeks of ART. ND, not detected. Cells in the table that are blank means the tissue was not available, * means the animal was female.

A. Tenofovir (TFV) TFV (ng/ml) IC TFV-DP (foml/10^6 cells) Ratio to PBMC ID Plasma PBMC LN GALT RALT LN GALT RALT DC1G * 4783.33 3405 1812.5 4516 0.71 0.38 0.94 DCCP 83.06 3125 1530 10167 4153 0.49 3.25 1.33 DCT2 45.62 1532.89 1425 487.5 699 0.93 0.32 0.46 DCLI 41.14 1347.83 1635 587.5 785 1.21 0.44 0.58 DCEA 93.52 1652.34 2950 421.88 1213 1.79 0.26 0.73 DCEW 65.92 1925 1432.5 922.06 3545 0.74 0.48 1.84 B. Emtricitabine (FTC) FTC (ng/ml) IC FTC-TP (fmol/10^6 cells) Ratio to PBMC ID Plasma PBMC LN GALT RALT LN GALT RALT DC1G * 4000 333.5 411 911 0.08 0.10 0.23 DCCP 61.0 2033 220 4861 724 0.11 2.39 0.36 DCT2 36.58 670.23 224.5 256.25 265 0.33 0.38 0.40 DCLI 31.23 457.61 270 364.42 126 0.59 0.80 0.28 DCEA 70.44 1304.69 346.25 178.91 354 0.27 0.14 0.27 DCEW 45.84 878.13 220.63 230.88 470 0.25 0.26 0.54 C. Darunavir (DRV) DRV (ng/ml) IC DRV (fmol/10^6 cells) Ratio to PBMC ID Plasma PBMC LN GALT RALT LN GALT RALT DC1G * BLQ BLQ BLQ 6531 NA NA NA DCCP 59.6 172.5 BLQ BLQ 68611 NA NA 397.75 DCT2 188.7 225.33 BLQ BLQ 1007 NA NA 4.47 DCLI 275.9 114.13 BLQ BLQ 1722 NA NA 15.09 DCEA 43.7 41.02 BLQ BLQ 406 NA NA 9.89 DCEW 77.0 153.91 BLQ BLQ 19773 NA NA 128.50 Supplementary Table 3: Plasma and intracellular ARV drug concentrations. Samples where concentrations were below the limit of quantitation are noted as BLQ; ratios that could not be calculated are noted as NA, not available.

vrna+ cells Virus-producing cells 18 12 18 17 Supplementary Table 4: Direct comparison of frequency of vrna+ cells in multiple sections from a LN of a suppressed macaque to the frequency of virus producing cells using ISH TSA/ELF. 1. Fremming BD, Benson RE, Young RJ. Weights of organs in sixty-six male Macaca mulatta monkeys. J Appl Physiol. 1955;8(2):155-8. PubMed PMID: 13263256.